Annual General Meeting

Annual General Meeting

Annual General Meeting 2020

BioNTech’s Annual General Meeting took place on Friday, June 26, 2020 online, without the physical presence of shareholders or their proxies. 82.08 percent of the registered share capital was represented and the shareholders approved all resolutions. The Voting Results and Speeches can be accessed below.

 

DOCUMENTS AND INFORMATION FOR THE VIRTUAL AGM

Invitation to the 2020 Annual General Meeting

Invitation to the 2020 AGM Convenience Translation

Voting Results 2020

 

Documents relating to Agenda Item 1

BioNTech SE_Annual Financial Statements 2019_Convenience Translation

BioNTech_Group Financial Statements 2019_Convenience translation

BioNTech SE_Annual Management Report 2019_Convenience Translation

BioNTech_Group Management Report 2019_Convenience translation

Bericht des Aufsichtsrats zum Geschäftsjahr 2019

 

Explanation to Agenda Item 1

Explanatory Notes on Agenda Item 1 s124a sentence 1 no. 2 Stock Corporation Act (AktG)

 

Documents relating to Agenda Item 6

Report of the Management Board on the Exclusion of Subscription Rights

 

Documents relating to Agenda Items 6 and 7

BioNTech SE Articles of Association Convenience Translation

 

Documents relating to Agenda Item 8

Sample Domination Agreement Convenience Translation

Sample Domination and Profit and Loss Transfer Agreement Convenience Translation

BioNTech IVAC GmbH (vormals Business Services) GuV und Bilanz 2017-2019

BioNTech Real Estate Holding GmbH (vormals AptaIT) GuV und Bilanz 2017-2019

BioNTech Small Molecules GmbH GuV und Bilanz 2017-2019

BioNTech Cell & Gene Therapies GmbH GuV und Bilanz 2017-2019

JPT Peptide Technologies GmbH GuV und Bilanz 2017-2019

Domination Agreement BioNTech IVAC GmbH Joint Report Convenience Translation

Domination Agreement BioNTech Real Estate Holding GmbH Joint Report Convenience Translation

Domination Agreement BioNTech Small Molecules GmbH Joint Report Convenience Translation

Domination and Profit and Loss Transfer Agreement BioNTech Cell & Gene GmbH Joint Report Convenience Translation

Domination and Profit and Loss Transfer Agreement JPT Peptide Technologies GmbH Joint Report Convenience Translation

 

Further Information and Forms

Explanatory Notes on Shareholders’ Rights

Registration, Voting and Proxy Form

 

Total Number of Shares and Voting Rights

Total Number of Shares and Voting Rights

 

Countermotions and Election Proposals

There are currently no countermotions and election proposals from shareholders.